Back to search

Article

Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: <i>In silico</i> analysis

2020-07-01

Abstract excerpt

<h4>ABSTRACT</h4> The novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has previously never been identified with humans, thereby creating devastation in public health. The need for an effective vaccine to curb this pandemic cannot be overemphasized. In view of this, we, therefore, designed a subcomponent antigenic peptide vaccine targeting the N-terminal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3377c4ee-42bd-539d-9636-0b0274c0ce9e
DOI
10.1101/2020.06.30.176537
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: <i>In silico</i> analysisDOI 10.1101/2020.06.30.176537
Attenuated Subcomponent Vaccine Design Targeting the SARS‐CoV‐2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico AnalysisSemantic proximity
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity
Multi-epitope Based Peptide Vaccine Design Using Three Structural Proteins (S, E, and M) of SARS-CoV-2: An <i>In Silico</i> ApproachSemantic proximity
The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachSemantic proximity
Immunoinformatics design of Bivalent Vaccine targeting S1-NTD and HA2 to simultaneously protect against SARS-CoV-2 and Influenza infectionsSemantic proximity
Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approachSemantic proximity
Immunoinformatics-Based Identification of B and T Cell Epitopes in RNA-Dependent RNA Polymerase of SARS-CoV-2Semantic proximity
Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategySemantic proximity
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an <i>in silico</i> approachSemantic proximity
<i>In Silico</i> design and characterization of multi-epitopes vaccine for SARS-CoV2 from its spike proteinsSemantic proximity
Engineering a Multi Epitope Vaccine Against SARS-CoV-2 By Exploiting Its Non Structural and Structural ProteinsSemantic proximity
Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniquesSemantic proximity
Select a neighboring publication to make it the new centre.